Viral Vaccines under Development: A Third Generation (Q38020832)

27 August 2017

1 reference

title

Viral vaccines under development: a third generation (English)

1 reference

27 August 2017

Viral Vaccines under Development: A Third Generation (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

17 January 2023

author name string

J. E. Osborn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A227237

17 January 2023

language of work or name

English

0 references

publication date

1 January 1979

1 reference

full work available at URL

27 August 2017

http://link.springer.com/content/pdf/10.1007/978-1-4684-0997-0_8.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Advances in Experimental Medicine and Biology

17 January 2023

published in

1 reference

27 August 2017

volume

118

1 reference

27 August 2017

page(s)

61-82

1 reference

Immunizations: Where the Money Should Be

27 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Viral Vaccines: New Problems and Prospects

17 January 2023

4

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

17 January 2023

7

55

73

FC Robbins

1977

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Animal rights advocate urges new deal

17 January 2023

9

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

New vaccine may bring man and chimpanzee into tragic conflict

17 January 2023

10

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Presence of human chromosome 21 alone is sufficient for hybrid cell sensitivity to human interferon

17 January 2023

11

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

SPECIFIC VIRAL INTERFERENCE IN HELA CELL CULTURES CHRONICALLY INFECTED WITH COXSACKIE B5 VIRUS

17 January 2023

12

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Molecular Biology of Papovaviruses

17 January 2023

13

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Cell DNA Replication as a Function in the Synthesis of Human Cytomegalovirus

17 January 2023

14

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Replication of human cytomegalovirus DNA: lack of dependence on cell DNA synthesis

17 January 2023

15

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Physiological State of Human Embryonic Lung Cells Affects Their Response to Human Cytomegalovirus

17 January 2023

16

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

RNA-directed DNA synthesis and RNA tumor viruses

17 January 2023

17

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Cytomegalovirus: conversion of nonpermissive cells to a permissive state for virus replication

17 January 2023

18

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

DNA modification and restriction

17 January 2023

19

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Restriction and Modification of DNA

17 January 2023

20

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

A variant Sendai virus, infectious to egg embryos but not to L cells. III. Growth characteristics of myxoyiruses in tissue culture.

17 January 2023

21

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus

17 January 2023

22

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses

17 January 2023

23

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Virulence and attenuation of murine cytomegalovirus

17 January 2023

24

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Mouse salivary gland virus infections.

17 January 2023

25

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

The genome of simian virus 40.

17 January 2023

29

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Temperature-Sensitive Mutants of Herpesviruses

17 January 2023

30

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Variability in the structural polypeptides of herpes simplex virus 1 strains: potential application in molecular epidemiology

17 January 2023

31

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Correlation of virus polypeptide structure with attenuation of poliovirus type 1

17 January 2023

33

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin

17 January 2023

34

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Infectious herpesvirus DNA

17 January 2023

35

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Human cytomegalovirus DNA. I. Molecular weight and infectivity

17 January 2023

36

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Complement-fixing reactivity of Varicella-Zoster virus subunit antigens with sera from homotypic infections and heterotypic Herpes simplex virus infections

17 January 2023

37

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Live attenuated influenza virus vaccines. Strains with temperature-sensitive defects in P3 protein and nucleoprotein

17 January 2023

38

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Demonstration of a non-temperature-sensitive growth-restricting mutation in a ts mutant of influenza A virus: implications for live virus vaccine development

17 January 2023

39

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Common sequence at the 5' ends of the segmented RNA genomes of influenza A and B viruses

17 January 2023

41

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

From the National Institutes of Health: report of a workshop on respiratory syncytial virus and parainfluenza viruses

17 January 2023

43

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection

17 January 2023

44

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Report of a workshop: disease accentuation after immunization with inactivated microbial vaccines

17 January 2023

45

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection

17 January 2023

48

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

The Immunologic Response to Infection with Respiratory Syncytial Virus in Infants

17 January 2023

49

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Live respiratory syncytial virus vaccine administered parenterally

17 January 2023

50

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Immunisation against hepatitis B in man

17 January 2023

51

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

The virus of hepatitis, type B (first of two parts).

17 January 2023

52

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

The genome of hepatitis B virus

17 January 2023

53

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Vaccine against human hepatitis B

17 January 2023

54

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Oncogenic potential of new viral vaccines

17 January 2023

56

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Experimental infection of chimpanzees with the virus of hepatitis B.

17 January 2023

57

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Transmission of Type B Viral Hepatitis to Chimpanzees

17 January 2023

58

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections

17 January 2023

59

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Propagation of varicella-zoster virus in a diploid strain of embryonic thyroid cells from the rhesus monkey

17 January 2023

60

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

GROWTH OF VARICELLA-ZOSTER VIRUS IN HUMAN THYROID TISSUE CULTURES

17 January 2023

61

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Separation of infectious Varicella-Zoster virus from human embryonic lung fibroblasts

17 January 2023

62

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Varicella-Zoster Virus Vaccine

17 January 2023

64

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Varicella virus isolation from spinal ganglion

17 January 2023

65

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Diagnostic Skin Test Reactions with Varicella Virus Antigen and Clinical Application of the Test

17 January 2023

70

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Interferon, antibody, and other host factors in herpes zoster

17 January 2023

73

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero.

17 January 2023

74

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Immunisation trials with live attenuated cytomegalovirus TOWNE 125

17 January 2023

75

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Clinical Trials of Immunization with the Towne 125 Strain of Human Cytomegalovirus

17 January 2023

76

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II.

17 January 2023

77

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

17 January 2023

80

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans

17 January 2023

81

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Analysis of antigenic diversity among human cytomegaloviruses by kinetic neutralization tests with high-titered rabbit antisera

17 January 2023

82

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Patterns of cytomegaloviral complement-fixing antibody activity: a longitudinal study of blood donors.

17 January 2023

83

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Specific Impairment of Cell-Mediated Immunity in Mothers of Infants with Congenital Infection Due to Cytomegalovirus

17 January 2023

85

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers

17 January 2023

86

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Congenital Cytomegalovirus Infection Outcome for the Subsequent Sibling

17 January 2023

87

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Congenital cytomegalovirus infection

17 January 2023

88

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Maternal cytomegalovirus excretion and perinatal infection

17 January 2023

89

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Perinatal Cytomegalovirus Infection: Influence of Placentally Transferred Maternal Antibody

17 January 2023

90

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Prevention of Morbidity and Mortality of Wild Murine Cytomegalovirus by Vaccination with Attenuated Cytomegalovirus

17 January 2023

92

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Effect of Immunization of Mothers on Cytomegalovirus Infection in Suckling Mice

17 January 2023

93

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Virulence and attenuation of murine cytomegalovirus

17 January 2023

94

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Cytomegalovirus Infection in Guinea Pigs. I. Viremia during Acute Primary and Chronic Persistent Infection

17 January 2023

95

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Cytomegalovirus Infection in Guinea Pigs. II. Transplacental and Horizontal Transmission

17 January 2023

96

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Human Cytomegalovirus Immunization Prospects

17 January 2023

98

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Clinical Trials of Immunization with the Towne 125 Strain of Human Cytomegalovirus

17 January 2023

99

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Cytomegalovirus infection in the neonate and its prevention

17 January 2023

100

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Cytomegalovirus vaccination and renal transplantation

17 January 2023

101

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses

17 January 2023

102

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine

17 January 2023

103

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

Herpes Simplex Virus Vaccines

17 January 2023

104

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-0997-0_8

17 January 2023

Identifiers

0 references

1 reference